Description: Fiximac-CV consist of a third-generation cephalosporin antibiotic and a beta-lactamase inhibitor used to treat various bacterial infections caused by gram-positive and negative bacteria.
Dosage Form: Tablet
Route of Administration: Oral
Composition: Each film-coated tablet contains: Cefixime IP as a trihydrate equivalent to Anhydrous Cefixime 200 mg Potassium Clavulanate Diluted, IP equivalent to Clavulanic Acid 125 mg Excipients q.s.
Mechanism of Action: Cefixime exerts its antibacterial action by inhibiting the synthesis of bacterial cell walls through binding to penicillin-binding proteins, disrupting the formation of the cell wall and leading to bacterial cell death. Clavulanic acid contains a beta-lactam ring in its structure that binds in an irreversible way to beta-lactamases, preventing them from inactivating certain beta-lactam antibiotics, with efficacy in treating susceptible Gram-positive and Gram-negative infections.
Indications: Fiximac-CV tablets is indicated for the treatment of a wide range of bacterial infections targeting the Upper respiratory tract, Lower respiratory tract and Urinary tract.
Dosage: As prescribed by the physician.
Side effects: Nausea, Abdominal pain, diarrhoea, Dyspepsia, Flatulence, Fall in prothrombin activity, Transient elevations in SGPT, SGOT, alkaline phosphatase etc.
Contraindications: Fiximac-CV is contraindicated in patients with a known allergy to Cefixime or to the Cephalosporin group of antibiotics.
Drug Interactions: Fiximac-CV can interact with other drugs, potentially affecting their efficacy or increasing the risk of side effects. Some notable drug interactions include – Warfarin & Anticoagulants, Carbamazepine.
Storage: Protect from light and store below 30 °C.
Presentation: 10X1X10